Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Context Therapeutics Investor Presentation Deck slide image

Context Therapeutics Investor Presentation Deck

Recent and Key Anticipated Milestones ONA-XR Breast - AACR preclinical update Breast-ELONA trial initiation Breast ELONA trial Phase 1b data Breast - 2L/3L (post-CDK4/6) Phase 2 preliminary data Endometrial - Phase 2 preliminary data Granulosa Cell - Phase 2 preliminary data Claudin 6 Candidate selection IND submission 23 Context Therapeutics Inc. - Sept. 2022 1H 2022 1H 2022 2H 2022 2H 2022 2023 2023 Corporate 2024 2024
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube